Anticorps Polyclonal de lapin anti-ARL8A

• Phare
• Validé par KD/KO

ARL8A Polyclonal Antibody for IP, WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris et plus (1)

Applications

WB, IP, IF, ELISA

Conjugaison

Non conjugué

Publications

4

N° de cat : 17060-1-AP

Synonymes

ARL10B, ARL8A, GIE2

---

Galerie de données de validation

• 

  WB analysis of HeLa using 17060-1-AP

  WB result of ARL8A antibody (17060-1-AP; 1:2000; incubated at room temperature for 1.5 hours) with sh-Control and sh-ARL8A transfected HeLa cells.

• 

  WB analysis of mouse brain using 17060-1-AP

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 17060-1-AP (ARL8A Antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HepG2 using 17060-1-AP

  HepG2 cells were subjected to SDS PAGE followed by western blot with 17060-1-AP (ARL8A Antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

• 

  IP experiment of mouse brain using 17060-1-AP

  IP Result of anti-ARL8A (IP:17060-1-AP, 4ug; Detection:17060-1-AP 1:600) with mouse brain tissue lysate 3440ug.

---

Applications testées

• Résultats positifs en WB: tissu cérébral de souris, cellules HeLa, cellules HepG2
• Résultats positifs en IP: tissu cérébral de souris

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:1000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 2 publications below
• WB: See 3 publications below
• IF: See 1 publications below

Informations sur le produit

17060-1-AP cible ARL8A dans les applications de WB, IP, IF, ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Réactivité citée: rat, Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: ARL8A Protéine recombinante Ag10788
• Nom complet: ADP-ribosylation factor-like 8A
• Masse moléculaire calculée: 186 aa, 21 kDa
• Poids moléculaire observé: 22 kDa
• Numéro d’acquisition GenBank: BC015408
• Symbole du gène: ARL8A
• Identification du gène (NCBI): 127829
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

ARL8A (ADP-ribosylation factor-like protein 8A) is also named as ARL10B, GIE2 and belongs to the small GTPase superfamily. ARL8A is localized to lysosomes in mammalian cells (PMID: 16537643). In neurons, ARL8A mediates the anterograde axonal long-range transport of presynaptic lysosome-related vesicles that are required for presynaptic biogenesis and synaptic function. ARL8A is upregulated in many cancers such as endometrial cancer (PMID: 32070877), colorectal cancer (PMID: 30546056) and inflammatory breast cancer (PMID: 27648361), and has been associated with poor survival outcomes. ARL8A has a calculated molecular weight of 21 kDa.

Publications

Species	Application	Title
human	WB	Nat Commun; RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin.; Authors - Tal Keren-Kaplan
human	WB	Curr Biol; ARL8 Relieves SKIP Autoinhibition to Enable Coupling of Lysosomes to Kinesin-1.; Authors - Tal Keren-Kaplan
human,rat	IF	J Cell Biol; Specific KIF1A-adaptor interactions control selective cargo recognition.; Authors - Jessica J A Hummel ; KD Validated
human	WB	J Cell Sci; The Salmonella effector SifA initiates a kinesin-1 and kinesin-3 recruitment process mirroring that mediated by Arl8a and Arl8b.; Authors - Ziyan Fang ; KD Validated